Subsequent studies have confirmed that MECP2 mutations occur in 90–95% of RTT cases, although rarer variants (e.g., CDKL5, FOXG1) may present with Rett-like features (Bricker and Vaughn, 2024). This evidence concerns the gene MECP2 and Rett syndrome.